合成致死性を探求するための誘導性遺伝子不活化システムの開発
Ádám Tamás Sánta1,2,3, Alexandra Gráf1, Katalin Vincze-Kontár1
1HCEMM-HUN-REN BRC Mutagenesis and Carcinogenesis Research Group, Institute of Genetics, HUN-REN Biological Research Centre, H-6726 Szeged, Hungary.
NAR cancer
|February 25, 2026
まとめ
新しい誘導性遺伝子不活化システム(IGIS)プラットフォームは、がん研究のための遺伝子サイレンシングの正確なタイミングを可能にします。この方法により、BRCA1とRAD18の合成致死的な相互作用が明らかになり、BRCA欠損腫瘍の潜在的な治療標的が提供されます。
関連する概念動画
In-vitro Mutagenesis
17.1K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
17.1K
Conservative Site-specific Recombination and Phase Variation
6.9K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...
6.9K


